Table 3.
patient demographics for each pathologies
| Rheumatic | Degenerative | IE | DCM | Ischemic | SVD | ANOVA | |
|---|---|---|---|---|---|---|---|
| (27) | (12) | (6) | (20) | (7) | p | ||
| Age | 70.4 (9.4) | 71.3 (15.8) | 62.0 (20.0) | 66.2 (11.0) | 71.4 (4.3) | 58.3 (22.8) | n.s. |
| F/M | 17/10 | 6/6 | 1/5 | 13/7 | 1/6 | 3/0 | |
| Preop. | |||||||
| NYHA | 2.2 | 2.5 | 3.0 | 2.85 | 3.4 | 2.7 | n.s. |
| LVEF | 61.1 (13.4)a,b | 64.4 (16.1)c,d | 62.0 (20.0) | 34.9 (11.0)a,c | 36.2 (18.0)b,d | 67.9 (11.8) | <0.001 |
a, b, c, d p<0.05 by Tukey–Kramer honestly significant difference test
DCM, Dilated Cardiomyopathy; IE, Infective Endocarditis; SVD, Structural Degeneration; PMR Papillary Muscle Rupture; ANOVA. Analysis of Variance; NYHA, New York Heart Association Class; LVEF, Left Ventricular Ejection Fraction